Trinity's Next Gen Launch Report Shows Pharmaceutical Launches Deliver Strong Performance in the Face of Uncertainty

<p>New research finds 51% of U.S. drug launches exceeded Wall Street revenue expectations in 2025, with oncology products leading the way WALTHAM, Mass., Oct. 5, 2026 /PRNewswire/ -- Trinity, the leader in integrating human and artificial intelligence in life sciences commercialization,...</p>